Yang X - Search Results

1

Curcumin-encapsulated polymeric micelles suppress the development of colon cancer in vitro and in vivo.

Yang X, Li Z, Wang N, Li L, Song L, He T, Sun L, Wang Z, Wu Q, Luo N, Yi C, Gong C. Yang X, et al. Sci Rep. 2015 May 18;5:10322. doi: 10.1038/srep10322. Sci Rep. 2015. PMID: 25980982 Free PMC article.

2

Biodegradable polymeric micelle-encapsulated quercetin suppresses tumor growth and metastasis in both transgenic zebrafish and mouse models.

Wu Q, Deng S, Li L, Sun L, Yang X, Liu X, Liu L, Qian Z, Wei Y, Gong C. Wu Q, et al. Among authors: yang x. Nanoscale. 2013 Dec 21;5(24):12480-93. doi: 10.1039/c3nr04651f. Nanoscale. 2013. PMID: 24165931

3

In vitro and in vivo safety evaluation of biodegradable self-assembled monomethyl poly (ethylene glycol)-poly (ε-caprolactone)-poly (trimethylene carbonate) micelles.

Yang X, Cao D, Wang N, Sun L, Li L, Nie S, Wu Q, Liu X, Yi C, Gong C. Yang X, et al. J Pharm Sci. 2014 Jan;103(1):305-13. doi: 10.1002/jps.23800. Epub 2013 Nov 26. J Pharm Sci. 2014. PMID: 24282070

4

Polymeric nanoassemblies entrapping curcumin overcome multidrug resistance in ovarian cancer.

Gou Q, Liu L, Wang C, Wu Q, Sun L, Yang X, Xie Y, Li P, Gong C. Gou Q, et al. Among authors: yang x. Colloids Surf B Biointerfaces. 2015 Feb 1;126:26-34. doi: 10.1016/j.colsurfb.2014.12.012. Epub 2014 Dec 13. Colloids Surf B Biointerfaces. 2015. PMID: 25543980

5

Nanomedicine to overcome cancer multidrug resistance.

Yang X, Yi C, Luo N, Gong C. Yang X, et al. Curr Drug Metab. 2014;15(6):632-49. doi: 10.2174/1389200215666140926154443. Curr Drug Metab. 2014. PMID: 25255871 Review.

6

A novel TRAIL mutant-TRAIL-Mu3 enhances the antitumor effects by the increased affinity and the up-expression of DR5 in pancreatic cancer.

Huang M, Zhu H, Yi C, Yan J, Wei L, Yang X, Chen S, Huang Y. Huang M, et al. Among authors: yang x. Cancer Chemother Pharmacol. 2018 Nov;82(5):829-838. doi: 10.1007/s00280-018-3658-9. Epub 2018 Aug 24. Cancer Chemother Pharmacol. 2018. PMID: 30167846

7

Efficacy of anti-PD-1 antibody SHR-1210 as second-line treatment in hepatocellular carcinoma patient with sorafenib resistance: A case report.

Zhu H, Yang X, Zhao Y, Yi C. Zhu H, et al. Among authors: yang x. Medicine (Baltimore). 2019 May;98(20):e15755. doi: 10.1097/MD.0000000000015755. Medicine (Baltimore). 2019. PMID: 31096541 Free PMC article.

8

Treatment with Brivanib alaninate as a second-line monotherapy after Sorafenib failure in hepatocellular carcinoma: A case report.

Zhu H, Zhang C, Yang X, Yi C. Zhu H, et al. Among authors: yang x. Medicine (Baltimore). 2019 Mar;98(10):e14823. doi: 10.1097/MD.0000000000014823. Medicine (Baltimore). 2019. PMID: 30855507 Free PMC article.

9

Photothermal hydrogel platform for prevention of post-surgical tumor recurrence and improving breast reconstruction.

Yang X, Gao L, Wei Y, Tan B, Wu Y, Yi C, Liao J. Yang X, et al. J Nanobiotechnology. 2021 Oct 7;19(1):307. doi: 10.1186/s12951-021-01041-w. J Nanobiotechnology. 2021. PMID: 34620160 Free PMC article.

10

An in situ spontaneously forming micelle-hydrogel system with programmable release for the sequential therapy of anaplastic thyroid cancer.

Yang X, Zhang L, Zheng L, Wang Y, Gao L, Luo R, Li X, Gong C, Luo H, Wu Q. Yang X, et al. J Mater Chem B. 2022 Feb 23;10(8):1236-1249. doi: 10.1039/d1tb01904j. J Mater Chem B. 2022. PMID: 35119450

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75,472 results

Search Page

Filters